ARTICLE | Product R&D

Stem and deliver

Stem cell companies have found exosomal extensions of their cellular therapies

December 10, 2015 8:00 AM UTC

Exosomes, once considered cellular debris, are gaining a name in cancer as biopsy-free diagnostic agents, and in drug delivery for their ability to enter cells in a targeted manner. Now, Capricor Therapeutics Inc. wants to use the particles for regenerative medicine, and is preparing to announce its first program early next year.

Exosomes are membrane-enclosed particles shed by cells, that contain proteins, lipids and nucleic acids. (See "Enter Exosomes", page 9)...